A Categorical Boosting model integrating routine serological markers, age, and liver stiffness measurement predicted biopsy-confirmed significant fibrosis in patients with CLD of uncertain etiology with AUC 0.827, outperforming FIB-4, GPR, Forns Index and LSM alone.
Researchers retrospectively studied 503 patients with chronic liver disease of uncertain etiology who had liver biopsies at Union Hospital of Tongji Medical College. They trained 12 machine-learning models on routine clinical variables and liver stiffness measurement to predict significant fibrosis, with Categorical Boosting showing the best performance at AUC 0.827.
- Impact 30%
- 49
- Evidence 25%
- 95
- Scale 20%
- 35
- Confidence 15%
- 87
- Recency 10%
- 99
Updated Oct 9, 2026 · TRV-2026-1316
ace